A Study of the Natural History of Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Disease
Clinical trial NCT03774784 · TERMINATED
Trial details
- NCT number
- NCT03774784
- Sponsor
- Alnylam Pharmaceuticals
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2019-01-29
- Primary completion
- 2020-05-18
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.